From: BPRS domains, items and subgroups analyses, and CGI-I ratings in pooled data from non-interventional studies of aripiprazole once-monthly in schizophrenia (REACT study)
Total sample (n = 409)
Any comorbidity
65.5%
Depression
14.9%
Hypertension
9.3%
Obesity
7.3%
Anxiety
7.1%
Somnolence
6.6%
Extrapyramidal disorder
5.4%
Blood prolactin increased
5.1%